Tenidap

Discontinued Product

2580 has been discontinued.

View all Cyclooxygenases products.
说明: NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3
别名: CP 66248
化学名: (Z)-5-Chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indole-1-carboxamide
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for Tenidap

Tenidap is a NSAID that preferentially inhibits COX-1 (IC50 values are < 0.03, 1.2 and > 30 μM for COX-1, COX-2 and 5-lipoxygenase respectively). Inhibits formation of pro-inflammatory arachidonic acid metabolites in isolated human peripheral polymorphonuclear leukocytes. Opener of inward rectifying hKir2.3 channel (EC50 = 402 nM).

化合物库 for Tenidap

Tenidap is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。

技术数据 for Tenidap

分子量 320.75
公式 C14H9N2O3SCl
储存 Store at +4°C
纯度 ≥99% (HPLC)
CAS Number 120210-48-2
PubChem ID 54683953
InChI Key LXIKEPCNDFVJKC-QXMHVHEDSA-N
Smiles O=C1N(C(N)=O)C2=CC=C(Cl)C=C2/C1=C(O)\C3=CC=CS3

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

按产品操作查看相关产品

查看全部 Cyclooxygenase Inhibitors

关键词: Tenidap, Tenidap supplier, NSAID, cyclooxygenase, COX-1, inhibitors, inhibits, KIR23, openers, Cyclooxygenase, Oxygenases, Oxidases, Potassium, KIR, Channels, KATP, Inward, Rectifier, K+, CP66248, CP, 66248, rectifier, 2580, Tocris Bioscience

篇 Tenidap 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Tenidap 的引用文献。

Tenidap 的评论

目前没有该产品的评论。 Be the first to review Tenidap and earn rewards!

Have you used Tenidap?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.